IL107387A - Combination pediatric vaccine with enhanced immunogenicity of each vaccine component - Google Patents

Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Info

Publication number
IL107387A
IL107387A IL107387A IL10738793A IL107387A IL 107387 A IL107387 A IL 107387A IL 107387 A IL107387 A IL 107387A IL 10738793 A IL10738793 A IL 10738793A IL 107387 A IL107387 A IL 107387A
Authority
IL
Israel
Prior art keywords
vaccine
enhanced immunogenicity
component
tetanus
diphtheria
Prior art date
Application number
IL107387A
Other languages
English (en)
Other versions
IL107387A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL107387A0 publication Critical patent/IL107387A0/xx
Publication of IL107387A publication Critical patent/IL107387A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
IL107387A 1992-10-27 1993-10-25 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component IL107387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (2)

Publication Number Publication Date
IL107387A0 IL107387A0 (en) 1994-01-25
IL107387A true IL107387A (en) 1997-04-15

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107387A IL107387A (en) 1992-10-27 1993-10-25 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Country Status (23)

Country Link
EP (1) EP0594950B1 (ja)
JP (1) JPH07300427A (ja)
KR (1) KR100289224B1 (ja)
AT (1) ATE176157T1 (ja)
AU (1) AU669570B2 (ja)
CA (1) CA2109159A1 (ja)
CZ (1) CZ283587B6 (ja)
DE (2) DE69323264D1 (ja)
DK (1) DK0594950T3 (ja)
ES (1) ES2126616T3 (ja)
FI (1) FI934725A (ja)
GR (1) GR3029884T3 (ja)
HK (1) HK1009931A1 (ja)
HU (1) HU215149B (ja)
IL (1) IL107387A (ja)
LV (1) LV12271B (ja)
NO (1) NO308588B1 (ja)
NZ (1) NZ250029A (ja)
PL (1) PL174130B1 (ja)
RU (1) RU2121365C1 (ja)
SG (1) SG47725A1 (ja)
TW (1) TW256774B (ja)
UA (1) UA27754C2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
CA2222455C (en) * 1995-03-22 2013-05-28 Smithkline Beecham Biologicals S.A. A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9608612A (pt) * 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
EP1762246A1 (en) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Multivalent DTP-Polio vaccines
PT1296715E (pt) * 2000-06-29 2012-01-19 Smithkline Beecham Biolog Composição vacinal multivalente
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
ES2649048T3 (es) 2002-11-01 2018-01-09 Glaxosmithkline Biologicals S.A. Procedimiento de secado
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
KR101408113B1 (ko) 2005-06-27 2014-06-16 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
LV12271A (lv) 1999-05-20
HK1009931A1 (en) 1999-06-11
DE69323264T4 (de) 1999-10-14
CZ227293A3 (en) 1994-05-18
AU5029093A (en) 1994-05-12
FI934725A (fi) 1994-04-28
ATE176157T1 (de) 1999-02-15
RU2121365C1 (ru) 1998-11-10
NZ250029A (en) 1994-09-27
EP0594950B1 (en) 1999-01-27
HUT67239A (en) 1995-03-28
ES2126616T3 (es) 1999-04-01
KR940008698A (ko) 1994-05-16
AU669570B2 (en) 1996-06-13
UA27754C2 (uk) 2000-10-16
JPH07300427A (ja) 1995-11-14
NO933856D0 (no) 1993-10-26
PL174130B1 (pl) 1998-06-30
LV12271B (en) 1999-07-20
CA2109159A1 (en) 1994-04-28
IL107387A0 (en) 1994-01-25
HU9303028D0 (en) 1994-01-28
FI934725A0 (fi) 1993-10-26
NO308588B1 (no) 2000-10-02
CZ283587B6 (cs) 1998-05-13
SG47725A1 (en) 1998-04-17
HU215149B (hu) 2000-03-28
GR3029884T3 (en) 1999-07-30
KR100289224B1 (ko) 2001-05-02
DE69323264D1 (de) 1999-03-11
TW256774B (ja) 1995-09-11
DK0594950T3 (da) 1999-09-13
EP0594950A1 (en) 1994-05-04
NO933856L (no) 1994-04-28
DE69323264T2 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
GR3035081T3 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
HU913103D0 (en) Method for producing vaccines of oligosacharide conjugates
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
HUP0301413A1 (hu) Vakcinakészítmények
JPH04230634A (ja) 複合ワクチンのキヤリヤー分子としての、百日咳菌の繊維状赤血球凝集素
DK0754055T3 (da) Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder
Alexander et al. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®)
IL107387A (en) Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
EP0338265A3 (en) Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
EP0894008A1 (en) Method of producing immunogenic products and vaccines
Beuvery et al. Meningococcal group C polysaccharide/tetanus toxoid conjugate as immunogen.
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
Michon et al. Combination conjugate vaccines against multiple serotypes of group B streptococci
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force